Nivolumab is employed in the treatment of certain gynecological cancers, particularly advanced or recurrent cases. It has shown efficacy in treating cervical cancer, ovarian cancer, and endometrial cancer. The drug is usually considered when traditional treatments such as surgery, chemotherapy, and radiation have failed or are not suitable.
